Heska Third Quarter 2021 Financial Results and Earnings Call Scheduled for November 4, 2021
Heska Corporation (NASDAQ: HSKA) will release its third quarter 2021 financial results before the market opens on November 4, 2021. An earnings call is scheduled for 9 a.m. MT (11 a.m. ET) to discuss the outcomes. Investors can join the call by dialing specified numbers, with a conference ID of 2365183. A telephonic replay will be available starting at 2 p.m. ET on November 4 until November 18, 2021. Heska specializes in veterinary diagnostic and specialty products globally, offering various healthcare products and services.
- Scheduled release of Q3 2021 financial results on November 4, 2021, indicating timely communication with investors.
- Earnings call planned for 9 a.m. MT, showing transparency in discussing financial performance.
- None.
LOVELAND, Colo., Oct. 12, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, will report its third quarter 2021 financial performance in a press release before the market opens on Thursday, November 4, 2021. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results.
To access the conference call:
From within the United States, please dial 1-888-394-8218
From outside of the United States, please dial 1-323-701-0225
Reference Conference ID: 2365183
The earnings call will be webcast live from the Company's investor relations website at Heska Third Quarter 2021 Earnings Call Webcast.
A telephonic replay will be available at 2 p.m. ET on November 4 through 11:59 p.m. ET on November 18, 2021 and the webcast will be archived on the Company's website for 90 days.
To access the replay:
From within the United States, please dial 1-844-512-2921
From outside the United States, please dial 1-412-317-6671
Reference Replay Pin Number: 2365183
About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health. For more information, please visit www.heska.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/heska-third-quarter-2021-financial-results-and-earnings-call-scheduled-for-november-4-2021-301397846.html
SOURCE Heska Corporation
FAQ
When will Heska Corporation report its third quarter 2021 financial results?
What time is the earnings call for Heska Corporation's Q3 2021 results?
How can I access the replay of Heska's earnings call?